Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹4,687 Cr₹7,420 Cr₹187 Cr₹199 Cr₹169 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹4,687 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹4,687 Cr
Mar2025₹7,420 Cr
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹4,687 Cr
-36.84
Mar2025 ₹7,420 Cr
3,860.66
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,396.2 Cr -1.6% -2.3% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,431.0 Cr -2.3% 3% 12.3% Stock Analytics
DIVIS LABORATORIES ₹220,115.0 Cr 2.9% 22.7% 25.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,853.0 Cr -2.7% 2% 33.9% Stock Analytics
CIPLA ₹119,158.0 Cr 0.1% 3% -7% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr 2.4% -12.9% -9.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.6%

-2.3%

-4.8%

SENSEX

1.3%

1%

-2.9%


You may also like the below Video Courses